DOI QR코드

DOI QR Code

IL28B rs12979860 Gene Polymorphism in Egyptian Patients with Chronic Liver Disease Infected with HCV

  • Zekri, Abdel-Rahman N. (Virology and Immunology Unit., Cancer Biology Department, Faculty of Medicine, Cairo University) ;
  • Salama, Hosny (Tropical Medicine Department, Faculty of Medicine, Cairo University) ;
  • Medhat, Eman (Tropical Medicine Department, Faculty of Medicine, Cairo University) ;
  • Bahnassy, Abeer A. (Pathology Department, National Cancer Institute, Faculty of Medicine, Cairo University) ;
  • Morsy, Heba M. (Virology and Immunology Unit, Cancer Biology Department, Faculty of Medicine, Cairo University) ;
  • Lotfy, Mai M. (Virology and Immunology Unit, Cancer Biology Department, Faculty of Medicine, Cairo University) ;
  • Ahmed, Rasha (Tropical Medicine Department, Faculty of Medicine, Cairo University) ;
  • Darwish, Tarneem (Biomedical Informatics and Biostatistics, Faculty of Medicine, Cairo University) ;
  • Marei, Mohamad S. (Tropical Medicine Department, Faculty of Medicine, Cairo University)
  • Published : 2014.09.15

Abstract

Background: Egypt has one of the highest prevalences of hepatitis C virus (HCV) infection worldwide. Although the IL28B gene polymorphism has been shown to modify the course of chronic HCV infection, this has not been properly assessed in the Egyptian population. Materials and Methods: The IL28B rs12979860 single nucleotide polymorphism (SNP) was therefore examined in 256 HCV-infected Egyptian patients (group II) at different stages of disease progression and in 48 healthy volunteers (group I). Group II was subdivided into GII-A (chronic hepatitis patients, n=119), GII-B (post hepatitis cirrhosis, n=66) and GII-C (HCC on top of cirrhosis, n=71). Results: The C/T genotype was the commonest in all groups. It was more frequent in GI (52%) than in GII (48%). There was no significant difference in the frequency of C/T and C/C or T/T genotypes between groups and subgroups (p=0.82). Within the subgroups; the C/C genotype was more common in GII-B while C/T and T/T genotypes were more common in GII-C, though with no significant difference (p=0.59 and p=0.80). There was no significant association between IL28B rs12979860 SNP and viral load, ALT, AFP level, METAVIR scores for necro-inflammation and fibrosis, and Child-Pugh classification. Conclusions: 1) IL28Brs12979860 C/T genotype is the commonest genotype in HCV-associated CH and HCC in Egypt. 2) IL28Brs12979860 polymorphisms are not associated with disease progression or aggression (histological staging, severity of fibrosis in CH or the incidence of post-HCV HCC). 3) Differences in IL28Brs12979860 genotypes could be a consequence of environmental or ethnic variation.

Keywords

HCV;IL28B gene (rs12979860) polymorphism;chronic hepatitis;hepatocellular carcinoma

References

  1. Agundez JA, Garcia-Martin E, Maestro ML, et al (2012). Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liverdisease. PLoS One, 7, 37998. https://doi.org/10.1371/journal.pone.0037998
  2. Asselah T, De Muynck S, Broet P, et al (2012). IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C. J Hepatol. 56, 527-32. https://doi.org/10.1016/j.jhep.2011.09.008
  3. Bruix J, Sherman M (2011). Management of hepatocellular carcinoma: an update AASLD, practice guidelines. Hepatol, 53, 1020-2. https://doi.org/10.1002/hep.24199
  4. Cheng P, Cheng Y, Su MX, et al (2012). Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma. Asian Pac J Cancer Prev, 13, 3741-5. https://doi.org/10.7314/APJCP.2012.13.8.3741
  5. El-Awady MK, Mostafa L, Tabll AA, et al (2012). Association of IL28B snp with progression of Egyptian HCV genotype 4 patients to end stage liver disease. Hepat Mon, 12, 271-7. https://doi.org/10.5812/hepatmon.6064
  6. Eurich D, Boas-Knoop S, Bahra M, et al (2012). Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocelular carcinoma, graft fibrosis, and posttransplant activiral therapy. Transpl, 93, 644-9.
  7. Fabris C, Falleti E, Cussigh A, et al (2011). IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol. 54, 716-22 https://doi.org/10.1016/j.jhep.2010.07.019
  8. Falleti E, Bitetto D, Fabris C, et al (2011). Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. J Clin Immunol, 31, 891-9. https://doi.org/10.1007/s10875-011-9547-1
  9. Marabita F, Aghemo A, De Nicola S, et al (2011). Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis c and known date of infection. Hepatol, 54, 1127-34. https://doi.org/10.1002/hep.24503
  10. Missiha SB, Ostrowski M, Heathcote EJ (2008). Disease progression in chronic hepatitis C: modifiable and non-modifiable factors. Gastroenterol, 134, 1699-714. https://doi.org/10.1053/j.gastro.2008.02.069
  11. Morgan TR (2011). Chemoprevention of hepatocellular carcinoma in chronic hepatitis C. Rec Results Cancer Res, 188, 85-99.
  12. Rauch A, Kutalik Z, Descombes P, et al (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterol, 138, 1338-45. https://doi.org/10.1053/j.gastro.2009.12.056
  13. Rehermann B (2009). Hepatitis C virus versus innate and adaptive immune responses: a tale of co evolution and coexistence. J Clin Invest, 119, 1745-54. https://doi.org/10.1172/JCI39133
  14. Sarrazin C, Susser S, Doehring A, et al (2011). Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J Hepatol, 54, 1099-106.
  15. Thomas DL, Thio CL, Martin MP, et al (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature, 461, 798-801 https://doi.org/10.1038/nature08463
  16. Thompson A, Clark PJ, Fellay J, et al (2010). IL28B genotype is not associated with advanced hepatic fibrosis in chronic hepatitis C patients enrolled in the IDEAL study. Hepatol, 52, 437
  17. Thompson AJ, Clark PJ, Singh A, et al (2012). Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. J Hepatol, 56, 313-9. https://doi.org/10.1016/j.jhep.2011.04.021
  18. Zekri AR, Moharram RA, Mohamed WS, et al (2010). Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1. Eur J Gastroenterol Hepatol, 22, 450-6. https://doi.org/10.1097/MEG.0b013e3283329d00
  19. Zekri A, Hassan Z, Bahnassy A, et al (2012). Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus. Asian Pac J Cancer Prev, 13, 5433-8. https://doi.org/10.7314/APJCP.2012.13.11.5433
  20. Zekri A, Nassar A, El-Rouby M, et al (2013). Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation. Asian Pac J Cancer Prev, 14, 6721- 6 https://doi.org/10.7314/APJCP.2013.14.11.6721
  21. Zhang X-L, Lu Y, Yang S, et al (2014). An updated metaanalysis between the Association of XRCC1 Arg399Gln Polymorphism and Hepatocellular Carcinoma Risk. Asian Pac J Cancer Prev, 15, 3273-8. https://doi.org/10.7314/APJCP.2014.15.7.3273

Cited by

  1. High Resolution Melting Curve Assay for Detecting rs12979860 IL28B Polymorphisms Involved in Response of Iranian Patients to Chronic Hepatitis C Treatment vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1873
  2. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients vol.161, pp.11, 2016, https://doi.org/10.1007/s00705-016-3015-4
  3. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients vol.36, pp.12, 2016, https://doi.org/10.1089/jir.2016.0042
  4. Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review vol.25, pp.5, 2018, https://doi.org/10.1111/jvh.12871